Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 1966 AL 1980

The effects of exercise interventions on Parkinson's disease: A Bayesian network meta-analysis

Tang L, Fang Y, Yin J.

J Clin Neurosci. 2019 Dec;70:47-54. doi: 10.1016/j.jocn.2019.08.092. Epub 2019 Sep 13.

Risky behaviors and Parkinson disease: A mendelian randomization study

Grover S, Lill CM, Kasten M, Klein C, Del Greco M F, König IR.

Neurology. 2019 Oct 8;93(15):e1412-e1424. doi: 10.1212/WNL.0000000000008245. Epub 2019 Sep 16.

Livin' on the edge: Risky behaviors and Parkinson disease: Genes, environment, or both?

Savica R.

Neurology. 2019 Oct 8;93(15):653-654. doi: 10.1212/WNL.0000000000008236. Epub 2019 Sep 16.

Symptomatic, left-sided deep brain stimulation lead edema 6 h after bilateral subthalamic nucleus lead placement

Lee JJ, Daniels B, Austerman RJ, Dalm BD.

Surg Neurol Int. 2019 Apr 24;10:68. doi: 10.25259/SNI-125-2019. eCollection 2019.

Sexual dimorphisms in adult human neural, mesoderm-derived, and neural crest-derived stem cells

Greiner JFW, Merten M, Kaltschmidt C, Kaltschmidt B.

FEBS Lett. 2019 Dec;593(23):3338-3352. doi: 10.1002/1873-3468.13606. Epub 2019 Oct 2.

An update on PTEN modulators - a patent review

Boosani CS, Gunasekar P, Agrawal DK.

Expert Opin Ther Pat. 2019 Nov;29(11):881-889. doi: 10.1080/13543776.2019.1669562. Epub 2019 Sep 23.

Estimating dyskinesia severity in Parkinson's disease by using a waist-worn sensor: concurrent validity study

Rodríguez-Molinero A, Pérez-López C, Samà A, Rodríguez-Martín D, Alcaine S, Mestre B, Quispe P, Giuliani B, Vainstein G, Browne P, Sweeney D, Quinlan LR, Arostegui JMM, Bayes À, Lewy H, Costa A, Annicchiarico R, Counihan T, Laighin GÒ, Cabestany J.

Sci Rep. 2019 Sep 17;9(1):13434. doi: 10.1038/s41598-019-49798-3.

Ginger (Zingiber officinale Roscoe) in the Prevention of Ageing and Degenerative Diseases: Review of Current Evidence

Mohd Sahardi NFN, Makpol S.

Evid Based Complement Alternat Med. 2019 Aug 20;2019:5054395. doi: 10.1155/2019/5054395. eCollection 2019.

To scan or not to scan your Parkinson patient: that is the question!

Araújo R, van Rumund A, Bloem BR.

Pract Neurol. 2019 Dec;19(6):462-464. doi: 10.1136/practneurol-2019-002339. Epub 2019 Sep 18.

Unusual cause of treatable Parkinsonism

Wiblin L, Mitra D, Warren N.

Pract Neurol. 2019 Dec;19(6):518-520. doi: 10.1136/practneurol-2019-002225. Epub 2019 Sep 18.

Nonpharmacological Modulation of Chronic Inflammation in Parkinson's Disease: Role of Diet Interventions

Kalampokini S, Becker A, Fassbender K, Lyros E, Unger MM.

Parkinsons Dis. 2019 Aug 25;2019:7535472. doi: 10.1155/2019/7535472. eCollection 2019.

Advancing Gene-Targeted Therapies for Central Nervous System Disorders: Proceedings of a Workshop

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders; Stroud C, Bain L, editors.

Washington (DC): National Academies Press (US); 2019 Sep 20.

The Evolution of Quality of Life After Subthalamic Stimulation for Parkinson's Disease: A Meta-Analysis

Büttner C, Maack M, Janitzky K, Witt K.

Mov Disord Clin Pract. 2019 Aug 16;6(7):521-530. doi: 10.1002/mdc3.12819. eCollection 2019 Sep.

Animal venoms: therapeutic tools for tackling Parkinson's disease

de Oliveira Amaral H, Monge-Fuentes V, Biolchi Mayer A, Alves Campos GA, Soares Lopes K, Camargo LC, Ferroni Schwartz M, Galante P, Mortari MR.

Drug Discov Today. 2019 Nov;24(11):2202-2211. doi: 10.1016/j.drudis.2019.09.004. Epub 2019 Sep 17.

Targeting the Mitochondrial Pyruvate Carrier for Neuroprotection

Tang BL.

Brain Sci. 2019 Sep 18;9(9):238. doi: 10.3390/brainsci9090238.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias